Impact of blood transfusion on survival after nephrectomy for localized or locally advanced renal cancer

被引：3

作者：

Detree, P. ^{[1
,2
]}

Balssa, L. ^{[1
]}

Richard, V ^{[1
,2
]}

Francois, C. ^{[1
,2
]}

Barkatz, J. ^{[1
]}

Bernardini, S. ^{[1
]}

Chabannes, E. ^{[1
]}

Guichard, G. ^{[1
]}

Thiery-Vuillemin, A. ^{[2
,3
,4
]}

Kleinclauss, F. ^{[1
,2
,5
]}

Frontczak, A. ^{[1
,2
,5
]}

机构：

[1] Univ Hosp Besancon, Dept Urol Androl & Renal Transplantat, 3 Blvd Fleming, F-25000 Besancon, France

[2] Univ Franche Comte, F-25000 Besancon, France

[3] Univ Hosp Besancon, Dept Med Oncol, F-25000 Besancon, France

[4] INSERM, UMR 1098, F-25000 Besancon, France

[5] EA 4662, Nanomed Lab, Imagery & Therapeut, F-25000 Besancon, France

来源：

PROGRES EN UROLOGIE | 2022年 / 32卷 / 8-9期

关键词：

Kidney cancer; Renal cell carcinoma (RCC); Transfusion; Survival; CARCINOMA; IMMUNOMODULATION; GUIDELINES; OUTCOMES; SURGERY;

D O I：

10.1016/j.purol.2022.03.002

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

Summary Objective. - Several studies have reported blood transfusion were associated with a decrease of survival after oncological surgery. For kidney cancer, the effect of blood transfusion is still debated. The objective of this study was to determine the effect of blood transfusion after oncological nephrectomy on overall, specific and recurrence-free survival in a retrospective cohort of localized or locally advanced kidney cancer. Material and Methods. - We performed a monocentric retrospective analysis of all patients managed by surgery for localized or locally advanced renal cancer between January 2000 and December 2016. We compared overall and specific survival and recurrence-free survival between two groups: patients transfused and not transfused. Demographic, surgical and tumor characteristics were compared. Survival analyses were performed using univariate Cox regression and multivariate Cox proportional regression test.

引用

页码：577 / 584

页数：8

共 29 条

[1] Perioperative blood transfusion adversely affects prognosis after nephrectomy for renal cell carcinoma [J].

Abu-Ghanem, Yasmin ;

Zilberman, Dorit E. ;

Dotan, Zohar ;

Kaver, Issac ;

Ramon, Jacob .

UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2018, 36 (01) :12.e15-12.e20

[2] Perioperative blood transfusions for the recurrence of colorectal cancer [J].

Amato, A ;

Pescatori, M .

COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2006, (01)

[3] The use of haemostatic agent: Impact on perioperative outcomes of partial nephrectomy [J].

Arnoux, V. ;

Descotes, J. -L. ;

Fiard, G. ;

Terrier, N. ;

Boillot, B. ;

Thuillier, C. ;

Rambeaud, J. -J. ;

Long, J. -A. .

PROGRES EN UROLOGIE, 2013, 23 (05) :317-322

[4]

Bakal C W, 1993, J Vasc Interv Radiol, V4, P727, DOI 10.1016/S1051-0443(93)71958-2

[5] French ccAFU guidelines - Update 2018-2020: Management of kidney cancer [J].

Bensalah, K. ;

Albiges, L. ;

Bernhard, J. -C. ;

Bigot, P. ;

Bodin, T. ;

Boissier, R. ;

Correas, J. -M. ;

Gimel, P. ;

Hetet, J. -F. ;

Long, J. -A. ;

Nouhauda, F. -X., I ;

Ouzdid, I. ;

Rioux-Leclercq, N. ;

Mejean, A. .

PROGRES EN UROLOGIE, 2018, 28 :R5-R33

[6] Classification of surgical complications - A new proposal with evaluation in a cohort of 6336 patients and results of a survey [J].

Dindo, D ;

Demartines, N ;

Clavien, PA .

ANNALS OF SURGERY, 2004, 240 (02) :205-213

[7] The American Joint Committee on Cancer: the 7th Edition of the AJCC Cancer Staging Manual and the Future of TNM [J].

Edge, Stephen B. ;

Compton, Carolyn C. .

ANNALS OF SURGICAL ONCOLOGY, 2010, 17 (06) :1471-1474

[8] Blood use strategies in urologic surgery [J].

Gilbert, WB ;

Smith, JA .

UROLOGY, 2000, 55 (04) :461-467

[9] Transfusion-related immunomodulation and cancer [J].

Goubran, Hadi ;

Sheridan, David ;

Radosevic, Julia ;

Burnouf, Thierry ;

Seghatchian, Jerard .

TRANSFUSION AND APHERESIS SCIENCE, 2017, 56 (03) :336-340

[10]

Haute Autorite de Sante, TRANSF GLOB ROUG HOM

← 1 2 3 →